CompaniesDolor Technologies

Dolor Technologies

active
Clearfield, UT, United States
Website
About

Device for Injecting Fluids into Nasal Passage

Areas of Focus

Categories

Drug Delivery DeviceMountain West
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

2

As Collaborator

2

Total Enrollment

278

By Phase

PHASE2: 1PHASE1: 1PHASE4: 1EARLY_PHASE1: 1

By Status

TERMINATED: 3COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00504088
Hover over trial bars to see details

Recent Trials

NCT00516308Lead Sponsor
A Non-Randomized Study of the NightHawk Peripheral Plaque Excision System During Plaque Excision of Peripheral Arterial Disease
PHASE2Terminated
100 participants
Started: Aug 31, 2007 · Completed: Dec 31, 2007
NCT00679055Collaborator
A Study of How MK-0736 Affects Arterial Plaque (0736-006)(TERMINATED)
PHASE1Terminated
14 participants
Started: Mar 31, 2007 · Completed: Aug 26, 2008
NCT00504088Lead Sponsor
Plaque Removal Versus Open Bypass Surgery For Critical Limb Ischemia
PHASE4Terminated
Started: Oct 31, 2006
NCT00720577Collaborator
Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease.
EARLY_PHASE1Completed
164 participants
Started: Dec 31, 2005 · Completed: Aug 31, 2007
Funding History (1)
D
Jan 15, 2014
Filing
Locations (1)
Headquarters
Clearfield, UT, United States
Map

Loading map...